Human — controlled trial

Randomised controlled trials of tirzepatide, the approved medicine

Trial literature for the approved dual GIP/GLP-1 agonist product. As with semaglutide, the evidence attaches to the approved product rather than to research-grade powder of unverified identity.

Placeholder record

This entry marks a body of literature and where to find it rather than a single paper. It is kept out of search indexes until it is replaced by a full record.

Cited by

Tirzepatide
What the research on Tirzepatide actually shows
The indexed literature on Tirzepatide includes human clinical or observational records (5 human-clinical or observational records). This digest describes the shape of that evidence and links the records behind it. It does not judge whether Tirzepatide is safe or effective for any purpose, and nothing here is medical advice — the material sold by the vendors in this index is labeled for laboratory research use only.

Compounds examined

Tirzepatide

Study records state what a paper reported. PepIndex does not interpret findings, assess clinical significance, or restate results in language implying an application not present in the source. Last reviewed 23 Jul 2026.